Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Meta and Apple team up to make Muse AI models run better on Macs

October 15, 2026

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Advanced Drug Delivery Systems Market Sees Promising Growth, New Technological Advancements Driving Industry Forward
Press Release

Advanced Drug Delivery Systems Market Sees Promising Growth, New Technological Advancements Driving Industry Forward

By News RoomJanuary 25, 20243 Mins Read
Advanced Drug Delivery Systems Market Sees Promising Growth, New Technological Advancements Driving Industry Forward
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) — The “Global Advanced Drug Delivery Systems Market Report 2023” report has been added to ResearchAndMarkets.com’s offering.

The global advanced drug delivery systems market is witnessing significant growth, with a projected increase from $240.97 billion in 2022 to an anticipated $323.68 billion by 2027, demonstrating a robust compound annual growth rate (CAGR) of 6.0%.

The growth trajectory of the advanced drug delivery systems market is notably influenced by the rising prevalence of chronic diseases worldwide. Chronic conditions are long-standing health issues that require ongoing medical attention and, in many cases, limit day-to-day activities. This growing demand for effective management of such diseases is fostering advancements in drug delivery systems that specialize in targeted therapeutic administration, aimed at enhancing drug efficacy and reducing adverse side effects.

Technological Advancements in Drug Delivery
Leading players within the advanced drug delivery systems realm are pioneering technological developments to solidify market presence. Recent introductions such as oral thin film formulations for pediatric medications exemplify the forward-moving trend within the industry.
Geographically, North America currently leads the market with the largest share. However, the Asia-Pacific region is identified as the fastest-growing market, signaling a pivotal shift on the global landscape over the coming years.
The market’s composition features a diverse range of key players that span multinational corporations and specialized pharma firms. These entities play a crucial role in the development and distribution of innovative drug delivery solutions, catering to a wide array of therapy areas from cardiovascular and oncology to diabetes and central nervous system conditions.

Market Composition and Key Insights

  • The market encompasses several advanced drug delivery mechanisms, including oral, injectable, inhalable, transdermal, and transmucosal systems, each catering to different therapeutic needs.
  • Groundbreaking delivery vehicles such as liposomes, nanoparticles, and monoclonal antibodies are shaping a new era of personalized medicine.
  • Innovative technology applications like polymeric drug delivery and targeted drug delivery systems are set to redefine the industry standards.
  • The extensive application range covers numerous indications, with specific focus areas like urology, diabetes, and infectious diseases. Hospitals, specialized clinics, and clinical research centers are among the key end users.

Reflecting on the industry’s promising outlook, this report delivers a comprehensive analysis of current market dynamics, future projections, and evolving opportunities within the advanced drug delivery systems landscape. It critically examines the regional performances and competitive positioning, offering valuable insights for stakeholders and investors alike.

The strategic information provided herein is aimed at those seeking a thorough understanding of the intricate ecosystem of advanced drug delivery systems, underscoring the market’s significance across the healthcare and pharmaceutical sectors.

A selection of companies mentioned in this report includes

  • Pfizer Inc.
  • Johnson and Johnson Services Inc.
  • Roche Holding AG
  • Abbvie Inc.
  • Bayer AG
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca plc
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • 3M Company
  • Medtronic plc
  • Eli Lilly and Company
  • Boehringer Ingelheim GmbH
  • Amgen Inc.
  • Merck Group
  • Becton Dickinson and Company
  • Baxter International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Boston Scientific Corporation
  • Mylan N.V.
  • Astellas Pharma Inc.
  • Catalent Inc.
  • Nipro Corporation
  • AptarGroup Inc.
  • West Pharmaceutical Services Inc.
  • Gerresheimer AG
  • Insulet Corporation

For more information about this report visit https://www.researchandmarkets.com/r/xikq8q

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Advanced Drug Delivery Systems Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

vineyard vines Returns as Official Style of the Head Of The Charles® Regatta

Bigger & Better Than Ever: Laxmi & Chef Kunal Kapur Return With ‘Diwali Delights’ Season 2

2026 Chery International User Summit to Kick Off: LUXEED Set for Global Brand Launch

Going Asset Management Wins Capital’s Excellence Fund Award, Harnessing Technology to Enhance the Long-Term Value of Assets

Alation Honors 2026 AI Radicals Award Winners at revAlation

Supported Employment: Helping Individuals Build Meaningful Careers

“The Carbon Pursuit of Happiness” Premieres October 10: A New Chapter for In-Depth Dialogue on Health and Humanity

Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to 11 Million and Reaffirms 460 Million Fiscal 2027 Outlook

Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading

Editors Picks

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026

Latest News

Friends don’t let friends feed their data to AI agents

October 15, 2026

As bond yields rise, how to pick between a variable or fixed rate mortgage?

October 15, 2026

Carney says he expects nations, including U.S., to stay out of Alberta vote

October 15, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version